Neolpharma, Inc.

FDA Regulatory Profile

Neolpharma, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 6 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0326-2015, Class II) was initiated on December 17, 2014.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
6
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0326-2015Class IIAlprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, DistributDecember 17, 2014